ArticleProstate cancer and prostatic diseases2020

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.

Annika Herlemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.